Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -1.41% | +6.06% | +4.48% |
Apr. 24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.48% | 353M | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- PGEN Stock
- News Precigen, Inc.
- Precigen : Reports Positive Topline Results in Type 1 Diabetes Trial -- Stock Jumps 29% After-Hours